ecancer

Flexible dosing of bortezomib for multiple myeloma

Prof Michel Delforge - Catholic University, Leuven, Belgium

20 May 2011

Tailoring therapy in elderly myeloma patients

Prof Antonio Palumbo (University of Turin, Italy), Dr Keith Stewart (Mayo Clinic, Arizona, USA)

7 May 2011

Lenalidomide survival benefit as continuous therapy for multiple myeloma

Prof Gareth Morgan, Dr Philip McCarthy

7 May 2011

Oncoproteins and genes involved in the chromosomal translocations of APL

Prof Pier-Paolo Pandolfi - Harvard Medical School, Boston, USA

21 Apr 2011

The Cancer Genome Atlas (TCGA)

Dr Paul Spellman - National Cancer Institute, Bethesda, USA

21 Apr 2011

AACR 2011: New Phase I targeted cancer drugs

Dr Lori Friedman - Genentech, California, USA

20 Apr 2011

Psycho-social aspects of treating elderly patients: Expert roundtable

Prof Antonello Pinto, Dr Luzia Travado, Giora Sharf, Prof Joerg Hasford, Prof Gordon McVie

14 Apr 2011

Management of elderly lymphoma patients: Expert Roundtable

Prof Pier Luigi Zinzani, Prof Umberto Vitolo, Prof Bertrand Coiffier, Prof Miguel Canales, Prof Mathias Rummel

14 Apr 2011

Treatment of elderly multiple myeloma patients: Expert Roundtable

Prof Antonio Palumbo, Prof Jesús San Miguel, Dr Evangelos Terpos, Prof Meral Beksac, Prof Fernando da Costa, Prof Michel Delforge

14 Apr 2011

Treatment of poor prognosis AML: Expert roundtable

Dr Fernando Ramos, Prof Alan Burnett, Prof Gert Ossenkoppele, Prof Sergio Amadori

14 Apr 2011

Treatment of myelodysplastic syndrome: Expert Roundtable

Prof Aristoteles Giagounidis, Dr Antonio Almeida, Prof Norbert Vey, Prof Antonello Pinto, Prof Valeria Santini, Prof Antonello Pinto

14 Apr 2011

Treatment of elderly or unfit CLL patients: Expert Roundtable

Prof Michael Hallek, Dr Francesc Bosch, Prof Peter Hillmen, Prof Clemens-Martin Wendtner, Prof Robin Foà

14 Apr 2011

More from ecancer